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Abstract
Background: Bcl-3 as an oncoprotein is overexpressed in nasopharyngeal carcinoma (NPC).
Nedd4 binding protein 2 (N4BP2), which is located in the NPC susceptibility locus, is a Bcl-3 binding
protein. This study is aimed to explore the association between N4BP2 genetic polymorphism and
the risk of NPC.
Methods: We performed a hospital-based case-control study, including 531 sporadic NPC and
480 cancer-free control subjects from southern China. PCR-sequencing was carried out on Exons,
promoter region and nearby introns of the N4BP2 gene. The expression pattern of N4BP2 and Bcl-
3 was also analyzed.
Results: We observed a statistically significant difference in haplotype blocks ATTA and GTTG
between cases and controls. In addition, three novel SNPs were identified, two of which were in
exons (loc123-e3l-snp2, position 39868005, A/G, Met171Val; RS17511668-SNP2, position
39926432, G/A, Glu118Lys), and one was in the intron6 (RS794001-SNP1, position 39944127, T/
G). Moreover, N4BP2 was at higher levels in a majority of tumor tissues examined, relative to
paired normal tissues.
Conclusion: These data suggest that haplotype blocks ATTA and GTTG of N4BP2 is correlation
with the risk of sporadic nasopharyngeal carcinoma in the Southern Chinese population and N4BP2
has a potential role in the development of NPC.
Background
Bcl-3 was originally identified as expressed in chronic B
cell lymphocytic leukemia [1]. Many cell growth and sur-
vival promoters can induce Bcl-3 expression, and Bcl-3
overexpression has been detected in other cancers such as
nasopharyngeal carcinoma (NPC) [2,3]. Nedd4 binding
protein 2 (N4BP2, GenBank:AY267013) is a Bcl-3 bind-
ing protein, N4BP2 protein contains a polynucleotide
kinase domain (PNK) at the N-terminus and a Small MutS
Related (Smr) domain with nicking endonuclease activity
near C-terminus [3]. MutS is central to the DNA mismatch
repair (MMR) systems that are responsible for maintain-
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ing genome stability and protecting against mutation,
Mutations in these genes are linked to the development of
certain types of cancer [4,5]. Since N4BP2 contains a
MutS-related domain, N4BP2 may play a role in MMR.
NPC is an epithelial tumor with an exceptionally high
incidence in southern China, particularly in the Guang-
dong province [6,7]. Etiological and epidemiological
studies have suggested that susceptibility genes may deter-
mine the predisposition to developing NPC [8,9]. Previ-
ously, we reported the use of 382 polymorphic
microsatellite markers to identify a candidate susceptibil-
ity locus that mapped to chromosome 4p15.1-q12
(D4S2950-D4S2916) in a subset of NPC families [10].
Further analysis identified SNPs within or near this
region, strongly suggesting the presence of an NPC suscep-
tibility locus adjacent to the LOC344967 [11], very close
to the N4BP2 gene.
We thus hypothesized that SNPs or other variation in the
N4BP2 gene lead to a predisposition to developing NPC.
We further hypothesized that the N4BP2 gene plays a role
in tumorigenesis. To address these hypotheses, we exam-
ined N4BP2 haplotypes among NPC patients from south-
ern China. We also examined mRNA levels of Bcl-3 and
N4BP2 in NPC cell lines and tissues.
Methods
Subjects
A total of 531 sporadic NPC patients and 480 unrelated
age, sex-, and geographically-matched healthy individuals
from southern China were used for our case-control study.
NPC patients were recruited from Sun Yat-sen University
Cancer Center and the presence of differentiated non-
keratinizing NPC or undifferentiated NPC was confirmed
by histological analysis. Control subjects were recruited
from the People's Hospital of Guangdong Province. The
characteristics of cases and controls are shown in Table 1.
Although the incidence of NPC is generally higher among
males than females, no significant difference in sex distri-
bution existed between case and control groups in this
study. The average age in the control group was 37 ± 10,
and in the case group was 40 ± 10; thus the age distribu-
tion here is a good representation of the broader NPC
patient population given that NPC incidence peaks at the
relatively young age of 45.
DNA preparation
Genomic DNA was extracted from 5–10 ml peripheral
blood using the QIAamp DNA Blood Midi kit (Qiagen,
German).
Primer design
Between 250 and 400 bp of sequence surrounding SNPs
sites were submitted to the primer design program [12].
The primers used for SNPs are shown in Table 2.
PCR Amplification
Long-distance PCR was performed in a total volume of 15
μl containing 200 ng of genomic DNA, 1.5 μl 10× Buffer,
50 μM dNTPs, 0.3 μM each primer, and 1U Taq DNA
polymerase. Samples were amplified with each pair of
Table 2: Primers used for SNPs
Number RefSNP(RS) (NCBI) Forward primers(5'→3') Reverse primer(5'→3') Product size (bp)
SNP1 RS17439810 agctgacagtgttcggctct ggtcaacatgatgtccgaaa 257
SNP2 loc123-e3l-snp2a
SNP3 RS17511578 cttctcgtcctgggtctcc TGTCAGCTACAGCCAGTCCA 397
SNP4 RS17585937 acatgggccacaggaagtg aggcctgccagacacctg 266
SNP6 RS17511668-SNP2b TCTGTTCAATGCAAAATCCAA catcttGTGAAGGCAAAAATGA 389
SNP7 RS794001-SNP1c GCTTCATATATGCCAAGCATCA TTTTCTTCTTTTGTTTAAATCTGCATT 398
SNP9 RS2252352 agaTGCAGCTCAATCACCTA CAGAAGAAATTGCCTTACAGGA 300
SNP10 RS2271395 tccagtctagtcaaaatggtgaga aacacacagtgcaatttcttaactg 243
SNP11 RS1442855 TCATTTGCTTCAGCTTGTCA GGCCTTAAACCTTACTCCATCC 300
SNP12 RS2347044 TCTTGTGGTGAAATGTAGAATGC CCTGAGATTAACTACCCATATCAGC 368
a Primers for loc123-e3l-snp2 are same as RS17439810.
b primers for RS17511668-SNP2 are same as RS17511668
c RS794001-SNP1 are same as RS794001.
Table 1: Profile of the study subjects
Characteristic Control (n = 480) Case (n = 531) Chi square pa
Gender (Male/Female) 354/126 390/141 0.01 0.91
Age 37 ± 10 40 ± 10 0.86 0.44
ap value obtained from Chi-square TestJournal of Translational Medicine 2007, 5:36 http://www.translational-medicine.com/content/5/1/36
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primers described above as follows: 94°C for 3 min, 10
cycles of 94°C for 30 s, 63°C for 1 min, and 72°C for 1
min; 25 cycles of 94°C for 30 s, 58°C for 1 min, 72°C for
1 min, and a final extension at 72°C for 7 min. First-
round PCR products were diluted 5-fold for the second-
round of PCR. Round 2 PCR conditions were 94°C for 3
min, 10 cycles at 94°C for 30 s, 65°C for 1 min, and 72°C
for 1 min; 30 cycles at 94°C for 30 s, 62°C for 1 min, and
72°C for 1 min, and 72°C for 7 min. PCR products were
visualized on a 1.2% agarose gel, stained with ethidium
bromide, and visualized by a transilluminator.
Genotyping
PCR products were sequence using ABI377 or ABI3730
sequencers (PE Applied biosystem). Base calling, contig
assembly contigs, and mutation detection was performed
using Polyphred package (Polyphred, Phred/Phrap/
Consed) [13]. All traces were visually inspected by at least
two observers.
Statistical methods
Unrelated control samples were selected for analysis using
the Hardy-Weinberg Equilibrium (HWE) test using an
exact test. Standard EM algorithm was used to infer haplo-
type and estimate population frequency. Single marker
and haplotype association test and significance estima-
tion were performed using a permutation test.
Cell Culture and Treatment
NP69 (an SV40 large T antigen-immortalized nasopha-
ryngeal epithelial cell line) and NP69-LMP1 (NP69 cells
transfected with the LMP1 gene) were cultured in Kerati-
nocyte-SFM medium (GibcoBRL) with Bovine Pituitary
Extract and rEGF. C666-1 (a poorly differentiated
nasopharyngeal epithelial cell line carrying the Epstein-
Barr virus) was grown in RPMI 1640 supplemented with
10% fetal bovine serum (FBS, Hyclone, Utah, USA). CNE-
1 (a highly-differentiated nasopharyngeal epithelial cell
line), CNE-2 (a poorly differentiated nasopharyngeal epi-
thelial cell line) and Sune(a poorly differentiated
nasopharyngeal epithelial cell line carried Epstein-Barr
virus) were maintained in RPMI 1640 with 10% FBS.
Tissue collection and RT-PCR
A total of 21 tissues were collected from Sun Yat-sen Uni-
versity Cancer Center. Six paired matched tissues from dif-
ferent organs included esophagus, stomach, liver, lung,
cervix and breast; nine nasopharyngeal tissues contained
Table 3: Candidate SNPs
Number RefSNP Contig Position Variant Alleles Amino acid change MAF HWpval Genotyped (%)
SNP1 RS17439810 39867905 C, G Gln104Glu 0.058 0.195 74.0
SNP2 loc123-e3l-snp2 39868005 A, G Met171Val 0.271 0.999 81.4
SNP3 RS17511578 39868252 A, C Asn189His 0.063 0.978 74.8
SNP4 RS17585937 39868402 G, A 5'UTR 0.118 1.000 76.2
SNP6 RS17511668-SNP2 39926432 G, A Glu118Lys 0.067 1.000 89.9
SNP7 RS794001-SNP1 39944127 T, G intron 0.054 0.562 97.4
SNP9 RS2252352 39950655 T, T intron 0.368 0.327 96.1
SNP10 RS2271395 39961241 G, A Ala1587Thr 0.368 1.000 94.8
SNP11 RS1442855 43164843 G, A intron 0.164 0.946 82.5
SNP12 RS2347044 43273849 A, G intron 0.225 0.377 96.9
RefSNP(RS), SNP accession ID; HWpval, P value of Hardy-Weinberg equilibrium tests for control subjects; MAF, minor allele frequency; % 
Genotyped, Percent of samples successfully genotyped. New SNPs are shown in bold.
Table 4: SNP allele frequency comparison between cases and controls
Number Name Major Alleles Case, Control Ratiosa Chi square P value
SNP1 loc123-e3l-snp1 C, C 772:42 452:34 1.864 0.1722
SNP2 loc123-e3l-snp2 A, A 570:224 472:164 1.051 0.3053
SNP3 loc123-e3l-snp3 G, G 659:51 572:32 1.960 0.1615
SNP4 LOC344967 G, G 634:74 546:84 2.658 0.1031
SNP6 RS17511668-SNP2 G, G 802:66 670:40 2.419 0.1199
SNP7 RS794001-SNP1 T, T 890:48 728:44 0.282 0.5954
SNP9 RS2252352 T, T 574:320 493:301 0.809 0.3684
SNP 10 RS2271395 A, A 599:331 452:282 1.410 0.2350
SNP 11 RS1442855 G, G 646:128 565:109 0.035 0.8513
SNP 12 RS2347044 A, A 712:212 607:171 0.225 0.6351
a Case, Control Ratios = the frequency of Major Alleles: the frequency of Minor AllelesJournal of Translational Medicine 2007, 5:36 http://www.translational-medicine.com/content/5/1/36
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2 chronic nasopharynx inflammation (Inf.), 1 Differenti-
ated Carcinoma (DNK), 4 Undifferentiated Carcinoma
(NDNK), 1 low differentiated squamous carcinoma
(LDS) and 1 non-Hodgkin's lymphoma (NHL). RNA was
extracted using TRIZOL Reagent (Invitrogen, Carlsbad,
CA), and reverse transcription was performed using the
TaKaRa RNA PCR kit (AMV) Ver.3.0 (TaKaRa BIO, Shiga,
Japan). PCR to detect N4BP2 was performed using the fol-
lowing primers (N4BP2-L: 5'-AAAGGGAGACCCTTAT-
GTTTGA-3'; N4BP2-R: 5'-AAATCAAACCTCACTTGCATTT-
3') and Bcl-3 with primers (Bcl-3-L:5'-tcctctggtgaacctgccta-
3'; Bcl-3-R:5'-gaagaccattggagctgagg-3') and β-actin as con-
trol with primers (5'-acactgtgcccatctacgagggg-3' and 5'-
atgatggagttgaaggtagtttcgtggat-3').
Results
SNP analysis
We identified a total of twelve SNP associated with the
N4BP2 locus, four of which were upstream of the N4BP2
gene and eight which were within N4BP2 gene (Table 3).
Of the SNPs, five SNPs resulted in missense mutations.
Three novel SNPs were identified: loc123-e3l-snp2 (posi-
tion 39868005, allele A/G, resulting in amino acid change
Met171 to Val), RS17511668-SNP2 (position 39926432,
Table 5: Haplotype analysis
Block Haplotype Frequenciesa Case, Control Ratiosb Chi Square P Value
1(SNP1-4)
CAG 0.55 519.0:411.0, 420.2:357.8 0.557 0.4556
CGG 0.272 261.2:668.8, 204.2:573.8 0.724 0.3947
CAA 0.119 100.6:829.4, 103.0:675.0 2.368 0.1238
GAG 0.058 49.2:880.8, 50.6:727.4 1.149 0.2837
2(SNP6-7-9-10)
GTTA 0.542 521.4:426.6, 429.0:377.0 0.549 0.4589
GTCG 0.355 328.2:619.8, 294.3:511.7 0.684 0.4082
AGTA 0.047 40.4:907.6, 41.6:764.4 0.806 0.3692
ATTA 0.017 27.4:920.6, 2.7:803.3 16.903 3.93E-05
GTTG 0.016 4.6:943.4, 23.3:782.7 16.038 6.21E-05
GTCA 0.015 13.1:934.9, 12.9:793.1 0.14 0.7079
Bold type indicates significant difference between case and control.
a frequency of haplotype in total subjects.
bfrequency of haplotype: frequency of non-haplotype.
Table 6: Permutation test
Name Chi Square Permutation p-value
Block 2: ATTA 16.903 0.0007
Block 2: GTTG 16.038 0.0013
Block 1: CAA 2.368 0.8602
Block 1: GAG 1.149 0.9916
Block 2: AGTA 0.806 0.9992
Block 1: CGG 0.724 0.9997
Block 2: GTCG 0.684 0.9998
Block 1: CAG 0.557 1
Block 2: GTTA 0.549 1
Block 2: GTCA 0.14 1
LOC344967 2.658 0.8071
RS17511668-SNP2 2.419 0.8498
loc123-e3l-snp3 1.96 0.9218
loc123-e3l-snp1 1.864 0.9366
RS2271395 1.41 0.9807
loc123-e3l-snp2 1.051 0.9952
RS2252352 0.809 0.9991
RS794001-SNP1 0.282 1
RS1442855 0.035 1
RS2347044 0.225 1
10000 permutations performed.
Haplotype in bold is closely linked blockJournal of Translational Medicine 2007, 5:36 http://www.translational-medicine.com/content/5/1/36
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Expression of N4BP2 and Bcl-3 mRNA in cells and tissues Figure 1
Expression of N4BP2 and Bcl-3 mRNA in cells and tissues. (A) Expression of N4BP2 and Bcl-3 mRNA in nasopharyngeal 
epithelial cell lines. RT-PCR was performed with gene-specific primers and β-actin was used as a control. (B) Expression of 
N4BP2 and Bcl-3 mRNA in matched tissues. RT-PCR was performed with gene-specific primers and β-actin as a control. up-low: 
normal tissue; down-low: tumor tissue. (C) Expression of N4BP2 and Bcl-3 mRNA nasopharyngeal tissues. Inf.: chronic 
nasopharynx inflammation; NDNK: Undifferentiated Carcinoma; DNK: Differentiated Carcinoma; LDS: Low differentiated 
squamous carcinoma; NHL: non-Hodgkin's lymphoma.Journal of Translational Medicine 2007, 5:36 http://www.translational-medicine.com/content/5/1/36
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allele G/A, amino acid change Glu118 to Lys), and
RS794001-SNP1 (position 39944127, allele T/G,
intronic). However, allele frequency analysis revealed no
significant difference between case and control groups
(Table 4).
Haplotype analysis
Haplotype frequencies and distributions were estimated
using a standard EM algorithm. Interestingly, Four SNPs
(SNP6-7-9-10) combined haplotype Block 2 ATTA and
GTTG exhibited notable difference between case and con-
trol groups (Table 5). Permutation tests for allelic associa-
tion confirmed that block ATTA and GTTG are closely
linked (Table 6) and confirmed the difference of Block 2
ATTA and GTTG in cases and controls.
N4BP2 and Bcl-3 expressed in cells and tissues
Bcl-3 and N4BP2 were detected in all cell lines examined
(Figure 1A). Interestingly, gene expression levels appeared
to vary among the cell lines, with the lowest levels being
detected in the Sune line. N4BP2 and Bcl-3 mRNA levels
appeared to be higher in tumor than in matched normal
tissue (Figure 1B). N4BP2 and Bcl-3 were also detected in
nasopharyngeal tissues (Figure 1C). These observations
suggest that N4BP2 expression levels correlate with the
progression of cancer including NPC.
Discussion
We previously showed, by linkage analysis that an NPC
susceptibility locus maps to chromosome 4 near the
LOC344967. Here, we extend this analysis in an effort to
identify a bona fide NPC susceptibility gene. N4BP2 is a
candidate gene in this region, and we thus sought to
examine the correlation between genetic polymorphisms
in N4BP2, a mismatch repair gene, and the incidence of
NPC. SNPs have been shown to be extremely useful for
studying the association between genomic regions and
disease [14]. Several studies have demonstrated that poly-
morphic variation in mismatch repair genes contributes
to susceptibility to certain cancers [15,16]. In addition,
several pieces of evidence suggest that nasopharyngeal car-
cinogenesis is associated with individual susceptibility
caused by SNPs. Our results show that, although there is
no significant difference in SNPs between cases and con-
trols, there are two haplotypes, ATTA and GTTG, the dis-
tribution of which differed between case and control
groups. Just as the report that almost not any difference in
the allele frequencies of five SNPs within the TNFSF4 gene
individuals suffered from coronary artery disease versus
the controls while there were significantly more frequent
of the possible haplotypes from this five TNFSF4 SNPs in
individuals with coronary artery disease than controls
[17]. Insight into this paradox has been provided in a
recent review by Schaid [18]. Haplotypes, the grouping of
closely linked alleles on a chromosome, make an impor-
tant contribution to the study of the genetic basis of dis-
ease. Schaid [18] explained that for case-control studies,
methodological approach based on haplotype has more
advantage than single-locus analysis as the SNPs are in LD
with a causative diallelic locus; in particular, haplotype-
based methods have greater power when the marker alle-
les are in strong LD with causative alleles. Haplotype
methods are more useful for variants which are more
recently evolved, rarer and more causative than for vari-
ants which are older and more common. This may help
explain why the haplotypes ATTA and GTTG exhibit dif-
ferences in frequency between case and control groups
while individual SNPs do not.
N4BP2 is a Bcl-3 binding protein, and Bcl-3 is an onco-
protein that is overexpressed in certain cancers, including
NPC. Our analysis of N4BP2 and Bcl-3 expression levels
suggest that expression of these genes is correlated, sug-
gesting they may be co-regulated. We also found that
N4BP2 and Bcl-3 are expressed in all NPC cell lines exam-
ined and were higher for certain cancers. These observa-
tions are consistent with previous reports.
Conclusion
Above all, we found that two N4BP2 haplotypes, ATTA
and GTTG, are correlated with NPC. This will be useful for
predict the development of NPC. In addition, N4BP2 and
Bcl-3  mRNA levels were elevated in tumors, including
NPC tumors, which suggest new therapeutic targets for
fighting NPC.
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